SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocketman who wrote (5010)5/29/1998 5:55:00 PM
From: Vector1  Read Replies (1) of 9719
 
Thought you might find the following from a ML report issue today interesting

-

Pfizer Inc - 29 May 1998
2 What Has Changed?
<<text>>

Currently, Viagra is the only oral medication approved in the United States for erectile dysfunction. We want to make it clear that Viagra currently stands alone in this market and that other drugs in development with a similar mechanism of action are in early phase clinical trials. In particular, recent reports suggest that a drug known as IC351 from ICOS Corp. may be a potentially better product than Viagra due to fewer side effects. This drug, however, is only in Phase II clinical trials and should not be available to the market any time soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext